We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Portable MRI Compatible Surgical Robot Improves Patients Outcomes for Neurosurgery

By HospiMedica International staff writers
Posted on 24 May 2024

Neurosurgeons performing deep brain stimulation lead placements often encounter the challenge of brain shift, which can lead to inconsistent and suboptimal outcomes because the brain moves relative to the skull during surgery. More...

This issue results in 34% of these surgeries requiring a subsequent operation to remove or adjust the leads due to initial misplacement of the targets within the brain. Now, a compact, MRI-compatible surgical robot that facilitates intelligent intraoperative surgical planning and guidance through real-time soft tissue imaging aims to tackle the issue of brain shift during deep brain stimulation lead placements.

AiM Medical Robotics (AiM, Worcester, MA, USA) is set to launch its revolutionary stereotactic neurosurgery robot that is designed to overcome the challenges of accurate and safe intracranial placement of neuromodulation, ablation, and drug delivery devices. The AiM stereotactic neurosurgery robot enhances visualization, navigation, and control during procedures. Featuring an MRI-compatible robotic frame and integrated with cutting-edge neuro-navigation software, AiM’s system delivers exceptional precision and efficiency for deep brain interventions. By integrating intraoperative MRI guidance into routine use, AiM aims to enhance hospital efficiency, procedural consistency, and patient outcomes.

In a recent trial, AiM’s robotic system was used in a direct MRI-guided procedure for placing deep brain stimulation leads in a human cadaver, showcasing its capabilities entirely within an MRI suite. The procedure achieved high levels of efficiency and accuracy. Significantly, the trial demonstrated the system’s ability to detect and compensate for brain shifts during the operation that can affect surgical outcomes. AiM is currently preparing to conduct a new study to further validate its innovative robot for deep brain stimulation treatments in patients with Parkinson's Disease with the aim of using real-time MRI guidance for accurate placement of stimulation leads.

Related Links:
AiM Medical Robotics


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
12-Channel ECG
CM1200B
New
Warming Cabinet
EC1850BL
New
Mobile X-Ray Machine
MARS 15 / 30
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: the deep tissue in vivo sound printing (DISP) platform, which combines ultrasound with low-temperature–sensitive liposomes loaded with crosslinking agents (Photo courtesy of Elham Davoodi and Wei Gao/Caltech)

New Ultrasound-Guided 3D Printing Technique to Help Fabricate Medical Implants

3D bioprinting technologies hold considerable promise for advancing modern medicine by enabling the production of customized implants, intricate medical devices, and engineered tissues designed to meet... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.